Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design
Danielle C. Groves, Sarah Rowland‐Jones, Adrienn Angyal
Biochemical and Biophysical Research Communications (2020) Vol. 538, pp. 104-107
Open Access | Times Cited: 129

Showing 1-25 of 129 citing articles:

SARS-CoV-2 Variants of Concern
Jun Yong Choi, Davey M. Smith
Yonsei Medical Journal (2021) Vol. 62, Iss. 11, pp. 961-961
Open Access | Times Cited: 275
SARS-COV-2 Variants: Differences and Potential of Immune Evasion
Sandro Massao Hirabara, Tamires Duarte Afonso Serdan, Renata Gorjão, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 206
The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
Dandan Tian, Yanhong Sun, Jianming Zhou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 191
The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
Elisa Teyssou, Héloïse Delagrèverie, Benoît Visseaux, et al.
Journal of Infection (2021) Vol. 83, Iss. 4, pp. e1-e3
Open Access | Times Cited: 171
Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity
Hylemariam Mihiretie Mengist, Arnaud John Kombe Kombe, Daniel Mekonnen, et al.
Seminars in Immunology (2021) Vol. 55, pp. 101533-101533
Open Access | Times Cited: 105
Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies
Yuwen Zhou, Yao Xie, Liansha Tang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 101
The global epidemic of SARS‐CoV‐2 variants and their mutational immune escape
Dandan Tian, Yanhong Sun, Jianming Zhou, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 3, pp. 847-857
Open Access | Times Cited: 101
SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies
Ahmed M. Almehdi, Ghalia Khoder, Aminah Alchakee, et al.
Infection (2021) Vol. 49, Iss. 5, pp. 855-876
Open Access | Times Cited: 86
COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions
Wajihul Hasan Khan, Zohra Hashmi, Aditya Goel, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 85
SARS-CoV-2 new variants: Characteristic features and impact on the efficacy of different vaccines
Abbas Khan, Taimoor Ashraf Khan, Shughla Ali, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112176-112176
Open Access | Times Cited: 71
Omicron (B.1.1.529) - A new heavily mutated variant: Mapped location and probable properties of its mutations with an emphasis on S-glycoprotein
Chiranjib Chakraborty, Manojit Bhattacharya, Ashish Ranjan Sharma, et al.
International Journal of Biological Macromolecules (2022) Vol. 219, pp. 980-997
Open Access | Times Cited: 53
Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences
Reem Hoteit, Hadi M. Yassine
Vaccines (2022) Vol. 10, Iss. 6, pp. 919-919
Open Access | Times Cited: 38
A review of SARS-CoV-2 variants and vaccines: Viral properties, mutations, vaccine efficacy, and safety
Md. Aminul Islam
Infectious Medicine (2023) Vol. 2, Iss. 4, pp. 247-261
Open Access | Times Cited: 24
Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection
Andrey V. Letarov, Vladislav V. Babenko, Eugene E. Kulikov
Biochemistry (Moscow) (2020) Vol. 86, Iss. 3, pp. 257-261
Open Access | Times Cited: 57
SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence
Thi Loi Dao, Van Thuan Hoang, Philippe Colson, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 12, pp. 2635-2635
Open Access | Times Cited: 47
Physicochemical effect of the N501Y, E484K/Q, K417N/T, L452R and T478K mutations on the SARS-CoV-2 spike protein RBD and its influence on agent fitness and on attributes developed by emerging variants of concern
Robério Amorim de Almeida Pondé
Virology (2022) Vol. 572, pp. 44-54
Open Access | Times Cited: 35
The importance of accessory protein variants in the pathogenicity of SARS-CoV-2
Sk. Sarif Hassan, Pabitra Pal Choudhury, Guy W. Dayhoff, et al.
Archives of Biochemistry and Biophysics (2022) Vol. 717, pp. 109124-109124
Open Access | Times Cited: 28
Paying attention to the SARS-CoV-2 dialect : a deep neural network approach to predicting novel protein mutations
Magdalyn E. Elkin, Xingquan Zhu
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Mutational analysis of structural proteins of SARS-CoV-2
Shweta Jakhmola, Omkar Indari, Dharmendra Kashyap, et al.
Heliyon (2021) Vol. 7, Iss. 3, pp. e06572-e06572
Open Access | Times Cited: 39
Biochemical features and mutations of key proteins in SARS-CoV-2 and their impacts on RNA therapeutics
Li Zeng, Dongying Li, Weida Tong, et al.
Biochemical Pharmacology (2021) Vol. 189, pp. 114424-114424
Open Access | Times Cited: 35
Aptamers for Detection and Diagnostics (ADD): Can mobile systems process optical data from aptamer sensors to identify molecules indicating presence of SARS-CoV-2 virus? Should healthcare explore aptamers as drugs for prevention as well as its use as adjuvants with antibodies and vaccines?
Shoumen Datta
(2020)
Closed Access | Times Cited: 32
Mutations in the SARS-CoV-2 spike protein modulate the virus affinity to the human ACE2 receptor, an in silico analysis.
Joseph T. Ortega, Flor H. Pujol, Beata Jastrzȩbska, et al.
(2021) Vol. 20, pp. 585-600
Closed Access | Times Cited: 27
Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy
Amirmasoud Rayati Damavandi, Razieh Dowran, Sarah Al Sharif, et al.
Medical Microbiology and Immunology (2022) Vol. 211, Iss. 2-3, pp. 79-103
Open Access | Times Cited: 19
Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil
Natália Fintelman-Rodrigues, Aline de Paula Dias da Silva, Monique Cristina dos Santos, et al.
Emerging infectious diseases (2021) Vol. 27, Iss. 5, pp. 1446-1453
Open Access | Times Cited: 25
Inferring the Association between the Risk of COVID-19 Case Fatality and N501Y Substitution in SARS-CoV-2
Shi Zhao, Jingzhi Lou, Ka Chun Chong, et al.
Viruses (2021) Vol. 13, Iss. 4, pp. 638-638
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top